These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30001402)

  • 1. The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells.
    Dankert JT; Wiesehöfer M; Czyrnik ED; Singer BB; von Ostau N; Wennemuth G
    PLoS One; 2018; 13(7):e0200472. PubMed ID: 30001402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation of HAS3 by miR-10b and miR-29a in neuroendocrine transdifferentiated LNCaP prostate cancer cells.
    Czyrnik ED; Wiesehöfer M; Dankert JT; Wennemuth G
    Biochem Biophys Res Commun; 2020 Mar; 523(3):713-718. PubMed ID: 31948751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-147b induces neuroendocrine differentiation of prostate cancer cells by targeting ribosomal protein RPS15A.
    Natani S; Ramakrishna M; Nallavolu T; Ummanni R
    Prostate; 2023 Jul; 83(10):936-949. PubMed ID: 37069746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.
    Moritz T; Venz S; Junker H; Kreuz S; Walther R; Zimmermann U
    Tumour Biol; 2016 Aug; 37(8):10435-46. PubMed ID: 26846108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer.
    Fernandes RC; Toubia J; Townley S; Hanson AR; Dredge BK; Pillman KA; Bert AG; Winter JM; Iggo R; Das R; Obinata D; ; Sandhu S; Risbridger GP; Taylor RA; Lawrence MG; Butler LM; Zoubeidi A; Gregory PA; Tilley WD; Hickey TE; Goodall GJ; Selth LA
    Cell Rep; 2021 Jan; 34(1):108585. PubMed ID: 33406413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
    Tawadros T; Alonso F; Jichlinski P; Clarke N; Calandra T; Haefliger JA; Roger T
    Endocr Relat Cancer; 2013 Feb; 20(1):137-49. PubMed ID: 23207293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
    Noonan EJ; Place RF; Basak S; Pookot D; Li LC
    Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
    Kaukoniemi KM; Rauhala HE; Scaravilli M; Latonen L; Annala M; Vessella RL; Nykter M; Tammela TL; Visakorpi T
    Cancer Med; 2015 Sep; 4(9):1417-25. PubMed ID: 26129688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
    John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
    Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma.
    Dankert JT; Wiesehöfer M; Wach S; Czyrnik ED; Wennemuth G
    Sci Rep; 2020 Oct; 10(1):18022. PubMed ID: 33093529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
    Li F; Gu C; Tian F; Jia Z; Meng Z; Ding Y; Yang J
    Oncol Rep; 2016 May; 35(5):2859-65. PubMed ID: 26986507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
    Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
    J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The β
    Braadland PR; Ramberg H; Grytli HH; Urbanucci A; Nielsen HK; Guldvik IJ; Engedal A; Ketola K; Wang W; Svindland A; Mills IG; Bjartell A; Taskén KA
    Mol Cancer Res; 2019 Nov; 17(11):2154-2168. PubMed ID: 31395667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
    Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
    Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
    Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
    Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic activities of miR-148a and DNMT1: Ectopic expression of miR-148a impairs DNMT1 mRNA and dwindle cell proliferation and survival.
    Sengupta D; Deb M; Patra SK
    Gene; 2018 Jun; 660():68-79. PubMed ID: 29596883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.